Inventaire - your friends and communities are your best library

Rethinking the metastatic cascade as a therapeutic target

published in: Nature Reviews Clinical Oncology

date of publication: 2011-04-19

language: English

Cites articles 87

Date

Title

Authors

2011-03-01

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis

John M Ebos
2011-01-24

Differential expression of invasion promoting genes in childhood rhabdomyosarcoma.

Christopher Poremba, Ewa Koscielniak
2010-10-12

Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08.
2010-03-28

Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

Julie Teruya-Feldstein, Robert Weinberg, Ferenc Reinhardt, Li Ma, George W Bell
2010-12-22

Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer
2010-08-15

MicroRNAs and metastasis: little RNAs go a long way
2010-05-25

Breast cancer dormancy can be maintained by small numbers of micrometastases

Trevor A Graham, Tomas Alarcon, Nicholas A. Wright, Ian Tomlinson
2010-11-04

Does tumour dormancy offer a therapeutic target?

Ann F. Chambers
2010-12-14

Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
2010-02-08

Molecular MRI for sensitive and specific detection of lung metastases

Warren S. Warren, Carola Leuschner
2010-09-13

Analysis of the yield of phase II combination therapy trials in medical oncology

Mark J Ratain
2010-11-29

Lessons from the adjuvant bevacizumab trial on colon cancer: what next?

Hans Prenen, Rakesh Jain, Peter Carmeliet
2010-03-10

Challenges in the development of future treatments for breast cancer stem cells

Russell Milton
2010-12-01

Cancer stem cells - A therapeutic target?

Norman Maitland
2009-04-02

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Geert D'Haens, Sabine Tejpar, Claus-Henning Köhne, Eric Van Cutsem, Gunnar Folprecht, György Bodoky
2009-09-29

Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks

Sean Davis, Patricia Steeg
2009-04

Metastasis: from dissemination to organ-specific colonization
2009-02-01

Endocrine therapy plus zoledronic acid in premenopausal breast cancer

Michael Gnant, Michael A Fridrik, Florian Fitzal, Raimund Jakesz, Peter C Dubsky, Brigitte Mlineritsch, Gero Luschin-Ebengreuth, Sabine Pöstlberger, Vesna Bjelic-Radisic, Günther G Steger, Werner Kwasny, Michael Stierer
2009-02-23

Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates.

Karim Fizazi, Xavier Mariette
2009-02-26

Learning therapeutic lessons from metastasis suppressor proteins
2009-04-23

Clinical-translational strategies for the elevation of Nm23-H1 metastasis suppressor gene expression
2009-03-01

Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited

Peter Carmeliet
2009-03-03

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis
2009-03-03

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Oriol Casanovas, Gabriele Bergers
2009-05-18

Anti-VEGF therapy as adjuvant therapy: clouds on the horizon?
2009-02-01

A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors

Yvonne Paterson, Paulo Cesar Maciag, Matthew M Seavey, Zhen-Kun Pan, Anu Wallecha, Vafa Shahabi
2009-09-02

Inhibition of the hedgehog pathway in advanced basal-cell carcinoma

Bert Lum
2009-09-02

Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449

Stephen E. Gould
2009-06-01

Cancer micrometastases

Sabine Riethdorf, Catherine Alix-Panabières, Klaus Pantel
2009-04-01

Pathology: are circulating tumor cells predictive of overall survival?

Sabine Riethdorf
2009-09-18

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

Yi-Long Wu, Chandra Belani, Maciej Krzakowski
2008-06-24

New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells

Tamara L Lotan

Article - wd:Q37866635

Welcome to Inventaire

the library of your friends and communities

learn more